Nitrous Oxide Has No Effect in the Treatment of Alcohol Withdrawal Syndrome: A Double-Blind Placebo-Controlled Randomized Trial

2003 ◽  
Vol 23 (2) ◽  
pp. 211-214 ◽  
Author(s):  
H. Alho ◽  
T. Methuen ◽  
M. Paloheimo ◽  
K. Seppä ◽  
N. Strid ◽  
...  
2005 ◽  
Vol 20 (7) ◽  
pp. 511-519 ◽  
Author(s):  
Jean-Daniel Favre ◽  
Hervé Allain ◽  
Henri-Jean Aubin ◽  
Elisabeth Frija-Orvoen ◽  
Claudine Gillet ◽  
...  

2020 ◽  
Vol 48 (4) ◽  
pp. 030006052091005
Author(s):  
Yun Song ◽  
Xiaobin Xue ◽  
Haibin Han ◽  
Cuiluan Li ◽  
Jia Jian ◽  
...  

Objective To compare the efficacy of transcutaneous electrical acupoint stimulation (TEAS) combined with diazepam against diazepam alone for treatment of acute alcohol withdrawal syndrome (AWS). Methods In this double-blind randomized sham-controlled trial, men with acute AWS were randomly allocated to either a group treated with TEAS combined with diazepam (n = 57) or a control group treated with sham TEAS combined with diazepam (n = 60). Treatment was performed at four acupoints twice a day for 14 days. The Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar), visual analogue scale (VAS), Pittsburgh Sleep Quality Index (PSQI) and modified Epworth Sleepiness Scale (mESS) were used to evaluate treatment efficacy. Results All scores improved significantly in both groups during the trial. CIWA-Ar scores were lower in the TEAS group than in the control group from day 3 until the end of observation. VAS and mESS scores were also lower in the TEAS group than in the control group on day 7. VAS and PSQI scores were lower in the TEAS group on day 14. Conclusion Combining diazepam with TEAS may result in milder AWS symptoms than diazepam alone, improve sleep quality and reduce sleepiness.


1982 ◽  
Vol 10 (3) ◽  
pp. 160-165 ◽  
Author(s):  
R Agricola ◽  
M Mazzarino ◽  
R Urani ◽  
V Gallo ◽  
E Grossi

A double-blind, randomized trial is described which was designed to compare the clinical effect of 600 mg daily of carbamazepine (Tegretol®) and of tiapride (Sereprile®) in hospitalized patients with pre-delirium tremens. Physicians' assessment of patients' progress was made following 2, 4 and 7 days of treatment. Of the sixty patients admitted to the study, five dropped out for various reasons, leaving fifty-five patients who completed the study. Both drugs were effective in the treatment of alcohol withdrawal symptoms; no significant difference was found between the two treatments with respect to total symptoms' score and visual analogue scale assessment. Carbamazepine gave faster relief of symptoms and demonstrated a preferential action on symptoms like fear and hallucinations. No case of delirium tremens was observed in those patients who completed the trial.


1973 ◽  
Vol 18 (5) ◽  
pp. 385-387
Author(s):  
J.B. Frost

Forty patients admitted for the treatment of alcohol withdrawal were placed on either chlorpromazine or mesoridazine on a double-blind basis. No significant difference in rate or degree of improvement between the two groups was noted and both groups showed an improvement which was more marked in the first week of treatment. There were few significant side effects from either drug. Improvement on either therapeutic regime is predictable and both are effective in relieving or lessening agitation, tremulousness, hallucinations and anxiety in patients recovering from acute alcohol intoxication.


Sign in / Sign up

Export Citation Format

Share Document